Vice President of Sales Justyn Okoniewski will seek to increase market share for IHS's highly accurate syringe infusion system. CHESTER, N.Y.
, Aug. 5, 2024 /PRNewswire/ -- Innovative Health Sciences ("IHS" or the "Company"), a medical device company that creates state-of-the-art drug infusion solutions, announced today the expansion of its commercialization team to market the InsignisTM Syringe Infusion System. The System was cleared by FDA on March 1, 2024 , and features a 13.
5psi mechanical syringe driver and a highly accurate selectable rate flow control device (for intravenous and subcutaneous use), which brings affordable, effective, convenient infusion for patients in a variety of settings, including ambulatory, hospital, clinic, and home. As Vice President of Sales, Justyn Okoniewski will accelerate business growth and commercialization. Insignis is the first combination of an intravenous and subcutaneous non-electric infusion pump created for use with a highly accurate selectable rate flow control device.
The InsignisTM system brings a fresh, novel approach to the forefront of the infusion industry defined by convenience, safety, innovation, and autonomy as for SCIg patients are now empowered to select, titrate, and modify the flow rate in real-time. This revolutionary improvement in infusion technology is dramatically altering the infusion therapy experience by finally finding a solution to painful site reactions. With Insignis, patients can mitigate, reduce, and ev.